GluN1 (359-378), an antibody targeting the N-methyl-D-aspartate receptor (NMDAR), can cross the blood-brain barrier and is used in research on immune-based therapies for anti-NMDAR encephalitis [1].
* VAT and and shipping costs not included. Errors and price changes excepted